Close Menu

Benitec announced this week that John McKinley has resigned as chairman and CEO of the company. He will remain as a non-executive director, Benitec said.

According to the company, COO Sara Cunningham has become acting CEO. She joined Benitec in 2004 when it acquired Avocel, an RNAi company she co-founded. Prior to starting up Avocel, Cunningham was senior manager of business development at B-Bridge International. Before this, she served as strategic and international marketing manager at BD Biosciences Clontech.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.